Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: Serial angiographic and sonographic analysis

American Heart Journal

Volumn 153, Issue 6, 2007, Pages

  König, Andreas ^a   Leibig, Markus ^a   Rieber, Johannes ^a   Schiele, Thomas Michael ^a   Theisen, Karl ^a   Siebert, Uwe ^b   Gothe, Raffaella Matteucci ^b   Klauss, Volker ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY FOR HEALTH SCIENCES   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DEXAMETHASONE; METAL;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC PATIENT; CELL PROLIFERATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; INTIMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; STATISTICAL ANALYSIS; THERAPY EFFECT;

COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY VESSELS; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; STENTS; SYNDROME; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 34249294356     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.03.032     Document Type: Article

References (24)

1. Serruys P.W., Strauss B.H., Beatt K.J., et al. Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med 324 (1991) 13-17
2. Hoffmann R., Mintz G.S., Dussaillant R.G., et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 94 (1996) 1247-1254
3. Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor Tirofiban. N Engl J Med 344 (2001) 1879-1887
4. Libby P., and Theroux P. Pathophysiology of coronary artery disease. Circulation 111 (2005) 3481-3488
5. Hoffmeister H.M., Ehlers R., Buettcher E., et al. Comparison of C-reactive protein and terminal complement complex in patients with unstable angina pectoris versus stable angina pectoris. Am J Cardiol 89 (2002) 909-912
6. Yamashita H., Shimada K., Seki E., et al. Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris. Am J Cardiol 91 (2003) 133-136
7. Welt F.G., and Rogers C. Inflammation and restenosis in the stent era. Atherioscler Thromb Vasc Biol 22 (2002) 1769-1776
8. Patti G., Pasceri V., Carminati P., et al. Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol 95 (2005) 502-505
9. Liu X., De Scheerder J., and Desmet W. Dexamethasone-eluting stent: an anti-inflammatory approach to inhibit coronary restenosis. Expert Rev Cardiovasc Ther 2 (2004) 653-660
10. Lewis A.L., Tolhurst L.A., and Stratford P.W. Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantation. Biomaterials 23 (2002) 1697-1706
11. Liu X., Huang Y., Hanet C., et al. I. Study of anti-restenosis with the BiodivYsio dexamethasone-eluting stent (STRIDE): a first-in-human multicenter pilot trial. Catheter Cardiovasc Interv 60 (2003) 172-178
12. Hoffmann R., Langenberg R., Radke P., et al. Evaluation of a high-dose dexamethasone eluting stent. Am J Cardiol 94 (2004) 193-195
13. Versaci A., Gaspardone F., Tomai F., et al. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol 85 (2000) 92-95
14. Mehran R., Dangas G., Abizaid A.S., et al. Angiographic patterns of in-stent restenosis, classification and implications for long-term outcome. Circulation 100 (1999) 1872-1878
15. Thel M.C., Califf R.M., Tardiff B.E., et al. Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to minimize platelet aggregation and coronary thrombosis. Am J Cardiol 85 (2000) 427-434
16. Patti G., Chello M., Pasceri V., et al. Dexamethasone-eluting stents and plasma concentrations of adhesion molecules in patients with unstable coronary syndromes: results of the historically controlled SESAME study. Clin Ther 27 (2005) 1411-1419
17. Hoffmann R., Radke P.W., Ortlepp J.R., et al. Intravascular ultrasound comparative analysis of degree of intimal hyperplasia produced by four different stents in the coronary arteries. Am J Cardiol 94 (2004) 1548-1550
18. Moses J.W., Mehran R., Nikolsky E., et al. Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes. Analysis from the TAXUS-IV Trial. J Am Coll Cardiol 45 (2005) 1165-1171
19. Han S.H., Ahn T.H., Kang W.C., et al. The favourable clinical and angiographic outcomes of a high-dose dexamethasone-eluting stent: randomized controlled prospective study. Am Heart J 152 (2006) 887.e1-887.e7
20. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
21. Iakovou I., Schmidt T., Ge L., et al. Angiographic patterns of restenosis after paclitaxel-eluting stent implantation. J Am Coll Cardiol 45 (2005) 805-806
22. Versaci F., Gaspardone A., Tomai F., et al. Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study). J Am Coll Cardiol 40 (2002) 1935-1942
23. Albiero R., Nishida T., Adamian M., et al. Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents. Circulation 101 (2000) 2454-2457
24. Saia F., Lemos P.A., Lee C.H., et al. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction. A clinical and angiographic study. Circulation 108 (2003) 1927-1929